GSK_ Annual_Report_2021-22

GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 54 Name of Director Category of Directorship Number of Board Meetings attended Attendance at the last AGM held on 27 July 2021 *Number of Director-ships in other companies (including GSK) **Number of mandatory committee positions held in other companies Chairman Member Mr. S. Venkatesh Managing Director Executive 7 Yes 2 Nil 1 Mr. S. Williams Non-Executive 6 Yes 1 Nil Nil Ms. P. Thakur (upto 31.03.2022) Executive 7 Yes 2 Nil Nil *Excludes directorship held in Private Limited Companies, Foreign Companies and Section 8 Companies; ** Committees considered are Audit Committee and Stakeholders’ Relationship Committee as per Listing Regulations. Ms. P. Thakur resigned as Whole-time Director and Chief Financial Officer of the Company with effect from closing hours 31 March 2022 and Mr. J. Chandy was appointed as Whole-time Director & Chief Financial Officer with effect from 1 April 2022. Mr. M. Dawson would cease to be a Director with effect from 30 June 2022. M s. Renu Sud Karnad - Non-Executive Director & Chairperson (DIN: 00008064) Ms. Karnad is the Managing Director of HDFC Limited and in charge of the lending operations of HDFC and is responsible for spearheading HDFC’s expansion. Ms. Karnad holds a Master’s degree in Economics from the University of Delhi and a Bachelor’s degree in law from the University of Mumbai. She is also a Parvin Fellow - Woodrow Wilson School of International Affairs, Princeton University, U.S.A. Ms. Karnad brings with her rich experience and enormous knowledge in the mortgage sector, having been part of the nascent real estate & mortgage industry in India for over 40 years. She has been instrumental in building the retail distribution network at HDFC and has played a key role in introducing several innovative & customer friendly products and services in the mortgage market. Apart from being HDFC’s brand custodian, she is the guiding force behind the formulation of HDFC’s communication strategy and public image. Ms. Karnad is currently the President of the International Union for Housing Finance (IUHF), an association of housing finance firms present across the globe. She is a Member of the Audit Committee, Risk Management Committee, Nomination & Remuneration Committee and Chairperson of Stakeholders Committee of the Company. Sr No Directorship in listed entities Category of Directorship Expertise in Specific Functional Areas 1 HDFC Life Insurance Company Limited Non-Executive Director Finance, Economics, Sales & Marketing, Human Resources, Risk Management, Housing Finance, Real Estate and Infrastructure Sector 2 HDFC Asset Management Company Limited Non-Executive Director 3 Housing Development Finance Corporation Limited Managing Director 4 Unitech Limited - (Resignation has been submitted to the Govt. of India and the Company. However, withdrawal of nomination is awaited.) Nominee Director 5 HDFC Bank Nominee Director M r. Damodarannair Sundaram – Independent Director (DIN: 00016304) Mr. Sundaram’s experience spans corporate finance, business performance, monitoring operations, governance, mergers & acquisitions, talent / people management and strategy. Mr. Sundaram joined Hindustan Unilever Limited (HUL), the Indian listed subsidiary of Unilever plc, as a management trainee in June 1975 and served in various capacities including six years in Unilever, London as Commercial Officer: Africa and Middle East (1990-93) and as Sr. Vice President for South Asia and Middle East (1996-99). He was the Chief Finance Officer of HUL from April 1999 to March 2008 and as the Vice Chairman and CFO from April 2008 to July 2009. He is a two-time winner of the prestigious “CFO of the Year for FMCG Sector” award by CNBC TV18 (2006 and 2008). He was awarded as the ‘Best Independent Director in 2019’ by Asian Centre for Corporate Governance and Sustainability in December 2020. Mr. Sundaram is currently the Vice Chairman (Non- executive, Non-independent) of TVS Capital Funds in managing a growth capital Private Equity Fund Annexure ‘C’ Report on Corporate Governance